A detailed history of Eventide Asset Management, LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, Eventide Asset Management, LLC holds 67,825 shares of UTHR stock, worth $24.5 Million. This represents 0.43% of its overall portfolio holdings.

Number of Shares
67,825
Previous 67,825 -0.0%
Holding current value
$24.5 Million
Previous $21.6 Million 12.5%
% of portfolio
0.43%
Previous 0.38%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$228.26 - $319.04 $15.5 Million - $21.6 Million
67,825 New
67,825 $21.6 Million

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.4B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Eventide Asset Management, LLC Portfolio

Follow Eventide Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eventide Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eventide Asset Management, LLC with notifications on news.